全文获取类型
收费全文 | 955篇 |
免费 | 40篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 15篇 |
妇产科学 | 9篇 |
基础医学 | 49篇 |
口腔科学 | 8篇 |
临床医学 | 41篇 |
内科学 | 334篇 |
皮肤病学 | 16篇 |
神经病学 | 275篇 |
特种医学 | 13篇 |
外科学 | 95篇 |
综合类 | 4篇 |
预防医学 | 40篇 |
眼科学 | 2篇 |
药学 | 36篇 |
中国医学 | 1篇 |
肿瘤学 | 54篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 18篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 22篇 |
2017年 | 12篇 |
2016年 | 18篇 |
2015年 | 8篇 |
2014年 | 36篇 |
2013年 | 45篇 |
2012年 | 70篇 |
2011年 | 75篇 |
2010年 | 32篇 |
2009年 | 31篇 |
2008年 | 62篇 |
2007年 | 53篇 |
2006年 | 61篇 |
2005年 | 58篇 |
2004年 | 46篇 |
2003年 | 36篇 |
2002年 | 33篇 |
2001年 | 31篇 |
2000年 | 27篇 |
1999年 | 24篇 |
1998年 | 5篇 |
1997年 | 1篇 |
1996年 | 5篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 19篇 |
1990年 | 11篇 |
1989年 | 16篇 |
1988年 | 19篇 |
1987年 | 7篇 |
1986年 | 9篇 |
1985年 | 11篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1967年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有996条查询结果,搜索用时 15 毫秒
991.
Kakisaka Y Wang ZI Mosher JC Dubarry AS Alexopoulos AV Enatsu R Kotagal P Burgess RC 《Epilepsy research》2012,101(1-2):191-196
A movement compensation (MC) algorithm may help to evaluate seizure focus in magnetoencephalography despite patient movement. We report a boy whose ictal MEG focus was localized to the same sublobar region before and after head turning when MC was applied, but which was erroneously localized to a different area without MC. This study provides the first clinical evidence for utility of MC in magnetoencephalography for localizing focal seizures. 相似文献
992.
Bamias A Bozas G Antoniou N Poulias I Katsifotis H Skolarikos A Mitropoulos D Alamanis C Alivizatos G Deliveliotis H Dimopoulos MA 《European urology》2008,53(2):323-331
OBJECTIVES: To investigate potential prognostic and predictive factors in patients with androgen-independent prostate cancer (AIPC) treated with docetaxel chemotherapy. METHODS: This analysis included 94 consecutive AIPC patients who were treated between March 2001 and May 2006 with biweekly docetaxel 45 mg/m(2) (day 2) and estramustine 140 mg three dimes daily (days 1-3). RESULTS: Prostate-specific antigen (PSA) responses were observed in 45 of 84 evaluable patients (53%), whereas objective responses were observed in 16 of 40 patients with measurable disease (40%). Median survival (OS) was 16.2 mo (95% confidence interval [CI], 12.9-19.4) and median time to PSA progression (TTP) 5.0 mo (95%CI, 3.6-7.1). OS was independently associated with pain score baseline PSA and weight loss. Patients with only extraosseous disease had higher PSA response rate (87% vs. 49%, p=0.014) and superior TTP compared with patients with bone metastases with or without extraosseous disease (7.3 vs. 4.3 vs. 4 mo, p=0.002). Concurrent bone and extraosseous metastases were associated with worse prognosis compared with each site alone (median OS: 12.3 vs.19 vs.18.3 mo, p=0.007). CONCLUSIONS: Among patients with AIPC treated with biweekly docetaxel and estramustine, baseline PSA >100, existence of pain, weight loss, and simultaneous extraosseous and bone disease were associated with worse prognosis. Extraosseous metastases seem to be more sensitive than bone disease to this chemotherapy. 相似文献
993.
Nanas JN Tsagalou EP Nanas SN Terrovitis JV Tsolakis EJ Toumanidis S Papazoglou PD Alexopoulos GP Kanakakis J Anastasiou-Nana MI 《International journal of cardiology》2006,108(2):237-243
BACKGROUND: The aim of this study was to evaluate the long-term effect of combined intermittent dobutamine infusions (IDI) and oral amiodarone on reverse left ventricular (LV) remodeling and hemodynamics of patients with idiopathic dilated cardiomyopathy (IDC) and end-stage congestive heart failure (CHF). METHODS: This non-randomized, prospective, clinical trial included sixteen consecutive patients suffering from dyspnea for a mean of 76+/-43 months, who presented with acute cardiac decompensation and were weaned from dobutamine therapy after an initial 72-h infusion. They were then placed on a regimen of oral amiodarone, 400 mg/day and weekly IDI, 10 microg/kg/min, for 8 h. The long-term clinical outcomes and the effects of treatment on reverse LV remodeling (echocardiographic parameters) and hemodynamics were evaluated at 3, 6, and 12 months of follow up. RESULTS: A significant degree of reverse LV remodeling, hemodynamic improvements, and survivals >1.5 years were observed in 9 of the 16 patients (56%). In addition, 5 patients (31% of entire cohort) were weaned from IDI after a mean of 61+/-41 weeks, and 4 remained clinically stable for 116+/-66 weeks thereafter. At 12 months of follow-up, LV end-diastolic and end-systolic volume indices had decreased from 231+/-91 to 206+/-80 ml/m2 (P=0.002) and from 137+/-65 to 110+/-50 ml/m2 (P=0.003), respectively, right atrial pressure from 16+/-6 to 5.6+/-4 mm Hg, (P=0.031), and pulmonary capillary wedge pressure from 29+/-4 to 16+/-5.4 mm Hg, P=0.000, while LV ejection fraction had increased from 22+/-6% to 27.3+/-8% (P=0.006). CONCLUSIONS: In end-stage CHF due to IDC, long-term treatment with IDI and oral amiodarone caused reverse LV remodeling, and allowed permanent and successful weaning from IDI in 1/4 of patients. 相似文献
994.
995.
996.
Alex Alexopoulos MD PhD Maria Dakoutrou MD Msc Lamprini Nasi MD PhD Ioanna Thanopoulou MD Talia Kakourou MD PhD Louiza Kontara MD PhD Nikolaos Douladiris MD PhD Maria Galani MD Paraskevi Xepapadaki MD PhD Chrysoula Doxani MD PhD Theodoros Mprotsis PhD Elias Zintzaras PhD Nikolaos G. Papadopoulos MD PhD Christina Kanaka-Gantenbein MD PhD George P. Chrousos MD PhD 《Pediatric dermatology》2023,40(1):78-83